Information with regards to Melanoma
Dear Kent Community Health NHS Foundation Trust,
I would like to please request the following information:
The purpose of these questions is to understand the variability of treatment within your trust and in context to the rest of the country.
Q1. In the past 3 months (or the latest 3 months data you have available), how many melanoma patients were treated with:
• Bevacizumab (Avastin)
• Dacarbazine (DTIC)
• Trametinib (Mekinist)
• Dabrafenib (Tafinlar)
• Ipilimumab (Yervoy)
• Vemurafenib (Zelboraf)
• Nivolumab (Opdivo)
• Nivolumab + Ipilimumab (Opdivo + Yervoy)
• Pembrolizumab (Keytruda)
• Vemurafenib + cobimetinib (Zelboraf + Cotellic)
• Dabrafenib + Trametinib (Tafinlar + Mekinist)
• Braftovi (encorafenib) in combination with Mektovi (binimetinib) for BRAF V600 patients
• Other active systemic anti-cancer therapy [please state]
• Palliative care only
Q2. In the past 3 months (or the latest 3 months data you have available), how many metastatic melanoma patients were treated with the following:
• Ipilimumab
• Ipilimumab AND Nivolumab
• Nivolumab
• Pembrolizumab
• Dabrafenib AND Trametinib
• Any Other Targeted Therapy (Dabrafenib /Encorafenib AND Binimetinib /Trametinib /Vemurafenib /Vemurafenib AND Cobimetinib)
• Other active systemic anti-cancer therapy
• Palliative care only
Thank you for answering these questions.
Yours faithfully,
Ed Fryer
Dear Mr Fryer
Thank you for your request for information under the Freedom of
Information Act 2000. Under the Act we have 20 working days to respond to
a request, therefore we will aim to provide you with our response by 4
May 2022. However, please be advised that our resources have been
diverted to support our front-line colleagues who are working tremendously
hard to provide care for our patients, and to those in need of our
services. As you can hopefully understand, this is resulting in delays
responding to information requests. We apologise for any inconvenience
this may cause, we do remain committed to responding to your request and
will respond as soon as we are able.
Should our response to your request breach the statutory timeframe and you
remain unhappy with our response you have the right to complain to the
Information Commissioners Office. The Information Commissioner’s offices
will be closed for the foreseeable future, and are therefore unable to
receive correspondence via post but can be contacted at
[1]https://ico.org.uk/global/contact-us/
Should you need to contact us in the meantime, please quote reference
number 2022.002.
Kind regards
Freedom of Information Team
Kent Community Health NHS Foundation Trust
The Oast, Hermitage Court
Hermitage Lane, Maidstone
Kent, ME16 9NT
01622 211900
In accordance with GDPR Art. 6(1)(c) processing of your data by Kent
Community Health NHS Foundation Trust is necessary for compliance with its
legal obligation under the Freedom of Information Act 2000 to respond to
you. Please refer to the “access to information” section available on our
website: [2]https://www.kentcht.nhs.uk/about-us/acce...
Dear Mr Fryer
With regard to your request for information via the Freedom of Information
Act 2000, please find attached our response.
Kind regards
FOI Team
Kent Community Health NHS Foundation Trust
The Oast, Hermitage Court
Hermitage Lane, Maidstone
Kent, ME16 9NT
01622 211900
In accordance with GDPR Art. 6(1)(c) processing of your data by Kent
Community Health NHS Foundation Trust is necessary for compliance with its
legal obligation under the Freedom of Information Act 2000 to respond to
you. Please refer to the “access to information” section available on our
website: [1]https://www.kentcht.nhs.uk/about-us/acce...
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now